Differential disruption of EWS-FLI1 binding by DNA-binding agents. - Wikidata - awgldk - TriplyDB

Differential disruption of EWS-FLI1 binding by DNA-binding agents.

Differential disruption of EWS-FLI1 binding by DNA-binding agents.

http://www.wikidata.org/entity/Q34874355

about

Sequencing Overview of Ewing Sarcoma: A Journey across Genomic, Epigenomic and Transcriptomic Landscapes 18F-FLT Positron Emission Tomography (PET) is a Pharmacodynamic Marker for EWS-FLI1 Activity and Ewing Sarcoma.Gene expression signature based screening identifies ribonucleotide reductase as a candidate therapeutic target in Ewing sarcoma.Identification of Mithramycin Analogues with Improved Targeting of the EWS-FLI1 Transcription Factor Inhibition of CHK1 sensitizes Ewing sarcoma cells to the ribonucleotide reductase inhibitor gemcitabine.Advances in the Treatment of Pediatric Bone Sarcomas.

P2860

Q26801785-7DF4DD6C-C393-43C2-BAD0-5FABA1BEE863 Q37285365-6987F05D-5271-4A2D-9E64-ED8C39EEA52F Q37665228-DEE699E9-5198-4E36-A665-9692EDE0559E Q41739827-D2F167AD-AEDF-4C76-8C05-528006F0609B Q47130816-7B3BD5D5-2B53-4050-8C56-5B9F3D5AA389 Q50969326-9A86EE9A-022D-4F16-A38A-4FBFC6F69EC0

P2860

Differential disruption of EWS-FLI1 binding by DNA-binding agents.

http://www.wikidata.org/entity/Q34874355

description

2013 nî lūn-bûn

@nan

2013 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Differential disruption of EWS-FLI1 binding by DNA-binding agents.

@ast

Differential disruption of EWS-FLI1 binding by DNA-binding agents.

@en

Differential disruption of EWS-FLI1 binding by DNA-binding agents.

@nl

type

label

Differential disruption of EWS-FLI1 binding by DNA-binding agents.

@ast

Differential disruption of EWS-FLI1 binding by DNA-binding agents.

@en

Differential disruption of EWS-FLI1 binding by DNA-binding agents.

@nl

prefLabel

Differential disruption of EWS-FLI1 binding by DNA-binding agents.

@ast

Differential disruption of EWS-FLI1 binding by DNA-binding agents.

@en

Differential disruption of EWS-FLI1 binding by DNA-binding agents.

@nl

P1433

Q34874355-76D3903E-D7B6-4F92-8911-9DA275AE3FB5

P1476

Q34874355-9D19CA1E-644C-4EEB-A5E7-BB552A3B4552

P2093

Q34874355-44D71B5B-6C41-4565-9C3B-39A5135FEAE4

Q34874355-5AC91B0A-2C8C-44BE-B21D-9D13E8AF8283

P2860

Q34874355-08DFBC11-3593-4AE7-A898-18EF29E8AB71

Q34874355-1F77F1DE-54F2-4636-A6E4-8C992E7B73D1

Q34874355-27305F7E-0E91-42E4-B93B-4BCC8F2E089A

Q34874355-27AD1A7B-2701-439C-A611-B14CC6A0C0BE

Q34874355-36FB056F-7A70-42FE-B9B7-F02D14E19EAD

Q34874355-3C7B8341-F0DF-4D70-BB51-0B098E48481B

Q34874355-5072F9DB-025A-4E6B-8CEF-72363909E0D9

Q34874355-5D212442-209F-4802-9483-570071A1D890

Q34874355-65B6EC23-62DD-4AB3-B702-628D35363038

Q34874355-7D8A5046-815F-45CA-A7F8-09FC741AEC45

P304

Q34874355-2CE492C5-5019-46F9-9E30-5E9C4B8E9763

P31

Q34874355-D74EC3EF-9ABD-4A8C-9495-D4B84B453EC7

P356

Q34874355-E17C29D2-5273-445A-957E-7485BA4B5497

P433

Q34874355-B98A99C1-32FD-4AD4-8280-2A86C479DA79

P478

Q34874355-77F2707F-864D-4BDD-A297-D1F5A5CC5329

P50

Q34874355-893FB593-81AF-4669-92D4-1A304269257F

Q34874355-A2405C88-38D6-4DF0-AE0D-DB4E970ADF43

P577

Q34874355-A53BE50E-1BA2-4A34-8540-7199A21348DE

P5875

Q34874355-7882A649-B3EB-4F7C-9248-2A7E40FCD6F4

P698

Q34874355-35B3E2F8-FBF9-4306-8C97-1AD137987DFD

P932

Q34874355-E47671AA-69CC-4DDD-9712-584A82A688ED

P356

JOURNAL.PONE.0069714

P1433

P1476

Differential disruption of EWS-FLI1 binding by DNA-binding agents.

@en

P2093

Changmin Chen

http://www.w3.org/2001/XMLSchema#string

Diane R Wonsey

http://www.w3.org/2001/XMLSchema#string

P2860

The Ewing's sarcoma EWS/FLI-1 fusion gene encodes a more potent transcriptional activator and is a more powerful transforming gene than FLI-1

Expression profiling of EWS/FLI identifies NKX2.2 as a critical target gene in Ewing's sarcoma

Loss of tumorigenicity of Ewing's sarcoma cells expressing antisense RNA to EWS-fusion transcripts

Ecteinascidin 743 interferes with the activity of EWS-FLI1 in Ewing sarcoma cells

Genome-wide analysis of ETS-family DNA-binding in vitro and in vivo

Identification of an inhibitor of the EWS-FLI1 oncogenic transcription factor by high-throughput screening.

Modulation of NF-κB-dependent gene transcription using programmable DNA minor groove binders

Undifferentiated small round cell sarcomas with rare EWS gene fusions: identification of a novel EWS-SP3 fusion and of additional cases with the EWS-ETV1 and EWS-FEV fusions.

Ewing sarcoma 11;22 translocation produces a chimeric transcription factor that requires the DNA-binding domain encoded by FLI1 for transformation.

Microsatellites as EWS/FLI response elements in Ewing's sarcoma

P304

e69714

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0069714

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

Madeleine Lemieux

P577

2013-07-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

253336591

http://www.w3.org/2001/XMLSchema#string

P698

23894528

http://www.w3.org/2001/XMLSchema#string

P932

3718762

http://www.w3.org/2001/XMLSchema#string